[1]
I. A. Hanifiyah, Y. Nita, Libriansyah, and A. Ridwan, “A Systematic Review: Cost-Effectiveness of SGLT2 Inhibitors versus DPP-4 Inhibitors as Add-on to Metformin”, JFIKI, vol. 12, no. 2, pp. 256–263, Aug. 2025.